BPDA2

Overview

BPDA2 is a highly selective and competitive active site SHP2 inhibitor with IC 50 s of 92.0 nM, 33.39 μM, 40.71 μM for SHP2 , SHP1, SHP1B, respectively. DBDA2 downregulates mitogenic and cell survival signaling and RTK expression. BPDA2 suppresses SHP2 mediated signaling and breast cancer cell phenotypes.

Application

Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Signaling Pathways > SHP1 | Products > Signaling Pathways > SHP2

Product Information

• Catalog No.: HY-152208
• CAS No.: 2907659-86-1
• Molecular Formula: C24H30O5
• Molecular Weight: 398.49
• Purity: 99.30%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source